Literature DB >> 22835739

The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).

Laura M Erhart1, Kacey C Ernst.   

Abstract

INTRODUCTION: Arizona had the highest hepatitis A incidence of any U.S. state during 1987-1997. In 1995, the first hepatitis A vaccines became available in the U.S. A series of hepatitis A vaccination policies and recommendations were implemented in 1996-2006. Our objective was to examine the shifting epidemiologic patterns in hepatitis A in Arizona from 1988 to 2007.
METHODS: Passive surveillance reports to the Arizona Department of Health Services were used to compare hepatitis A rates by age, race/ethnicity and geographic area, before and after widespread vaccination. Reported risk factors and possible sources of infection were compared for two time periods. Age-adjusted incidence during three periods was mapped.
RESULTS: Overall hepatitis A incidence in Arizona fell from 58 cases per 100,000 in 1988 to 2 per 100,000 in 2007. The proportion of reported cases among children dropped from 62% in 1994-1995 to 32% in 2006-2007. Racial/ethnic disparities between American Indians and non-Hispanic White populations have been eliminated. The geographic distribution of cases within the state has shifted. Earlier cases were likely to report contact with another hepatitis A case or childcare facilities, while later cases indicated recent international travel.
CONCLUSION: A major shift in the overall burden of hepatitis A and hepatitis A transmission has occurred in Arizona since the widespread implementation of immunization policies and the concomitant rise in vaccination rates in the state. Current transmission has shifted to older age groups and disparities by race/ethnicity are now highest in Hispanic populations. Future strategies to further reduce hepatitis A transmission may require broadening recommendations to include general adult populations without previous vaccination history.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835739     DOI: 10.1016/j.vaccine.2012.07.029

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

2.  The role of ethnicity and travel on Hepatitis A vaccination coverage and disease incidence in Arizona at the United States-Mexico Border.

Authors:  Kacey C Ernst; Laura M Erhart
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

3.  Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.

Authors:  Ana Martínez; Sonia Broner; M Rosa Sala; Sandra Manzanares-Laya; Pere Godoy; Caritat Planas; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez; The Working Group For The Study Of The Immune Status In Health Care; For The Study Of Hepatitis A In Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 4.  Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.

Authors:  Anke L Stuurman; Cinzia Marano; Eveline M Bunge; Laurence De Moerlooze; Daniel Shouval
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

Review 5.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

Review 6.  Advancing Liver Cancer Prevention for American Indian Populations in Arizona: An Integrative Review.

Authors:  Timian M Godfrey; Edgar A Villavicencio; Kimberly Barra; Priscilla R Sanderson; Kimberly Shea; Xiaoxiao Sun; David O Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-03-10       Impact factor: 3.390

7.  Underdiagnosis of foodborne hepatitis A, The Netherlands, 2008-2010(1.).

Authors:  Mariska Petrignani; Linda Verhoef; Harry Vennema; Rianne van Hunen; Dominique Baas; Jim E van Steenbergen; Marion P G Koopmans
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.